Daniel F Alonso Selected Research

Daniel F Alonso Research Topics

Disease

73	Neoplasms (Cancer) 12/2023 - 01/2002
25	Neoplasm Metastasis (Metastasis) 12/2023 - 01/2002
23	Breast Neoplasms (Breast Cancer) 01/2020 - 01/2002
17	Carcinoma (Carcinomatosis) 08/2023 - 01/2002
15	Melanoma (Melanoma, Malignant) 07/2012 - 03/2002
9	Lung Neoplasms (Lung Cancer) 01/2018 - 12/2003
7	Hemorrhage 10/2020 - 09/2002
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 08/2018 - 12/2007
6	Experimental Melanoma 07/2012 - 12/2002
5	Colorectal Neoplasms (Colorectal Cancer) 12/2023 - 01/2017
4	COVID-19 01/2022 - 09/2020
4	Retinoblastoma (Glioblastoma, Retinal) 12/2016 - 03/2010
4	Neuroblastoma 01/2016 - 03/2010
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2018 - 02/2007
2	Osteosarcoma (Osteogenic Sarcoma) 10/2023 - 01/2022
2	Glioma (Gliomas) 09/2022 - 01/2014
2	Colonic Neoplasms (Colon Cancer) 07/2020 - 12/2010
2	Disease Progression 01/2020 - 05/2008
2	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 01/2017
2	Lewis Lung Carcinoma 01/2017 - 01/2012
2	Circulating Neoplastic Cells 01/2016 - 01/2015
2	Carcinogenesis 01/2014 - 01/2012
2	Residual Neoplasm 09/2008 - 12/2006
2	Lymphatic Metastasis 11/2006 - 09/2002
1	Necrosis 01/2022
1	Rectal Neoplasms (Rectal Cancer) 10/2020
1	Body Weight (Weight, Body) 07/2020

Drug/Important Bio-Agent (IBA)

26	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 12/2023 - 09/2002
21	Peptides (Polypeptides)IBA 12/2023 - 01/2008
17	Vasopressins (Vasopressin)IBA 12/2023 - 09/2002
17	GangliosidesIBA 08/2018 - 03/2002
15	VaccinesIBA 12/2015 - 03/2002
12	CIGB-300IBA 01/2020 - 10/2004
8	Monoclonal AntibodiesIBA 08/2023 - 03/2002
8	EnzymesIBA 09/2018 - 01/2002
7	Vasopressin Receptors (Arginine Vasopressin Receptor)IBA 01/2019 - 11/2006
7	AntigensIBA 08/2018 - 03/2002
7	racotumomabIBA 08/2018 - 01/2010
7	Messenger RNA (mRNA)IBA 12/2016 - 05/2008
5	Arginine Vasopressin (Argipressin)IBA 12/2023 - 10/2008
5	Hemostatics (Antihemorrhagics)IBA 10/2020 - 09/2002
5	Cytostatic AgentsIBA 01/2020 - 01/2009
5	Casein Kinase II (Casein Kinase 2)IBA 01/2017 - 10/2004
5	von Willebrand FactorIBA 10/2015 - 11/2006
4	Antineoplastic Agents (Antineoplastics)IBA 10/2023 - 10/2010
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2016 - 01/2002
4	Proteins (Proteins, Gene)FDA Link 10/2011 - 01/2003
4	G(M3) GangliosideIBA 01/2011 - 12/2002
3	Antiviral Agents (Antivirals)IBA 09/2021 - 09/2020
3	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2020 - 10/2004
3	AntibodiesIBA 08/2018 - 02/2007
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2005
3	Cancer VaccinesIBA 07/2012 - 03/2002
3	Sulfoglycosphingolipids (Sulfatides)IBA 01/2012 - 02/2007
3	Cyclic PeptidesIBA 07/2011 - 10/2004
2	Cisplatin (Platino)FDA LinkGeneric 10/2023 - 01/2022
2	Ivermectin (Mectizan)FDA Link 09/2021 - 07/2021
2	Complement System Proteins (Complement)IBA 04/2019 - 01/2016
2	Transcription Factors (Transcription Factor)IBA 12/2016 - 07/2015
2	Carmustine (FIVB)FDA Link 01/2016 - 09/2008
2	valyl(4)-glutaminyl(5)- desmopressinIBA 01/2016 - 12/2011
2	aluminum sulfate (alum)IBA 01/2016 - 01/2012
2	Monomeric GTP-Binding ProteinsIBA 01/2014 - 01/2014
2	(N- acetylneuraminyl)- galactosylglucosylceramide N-acetylgalactosaminyltransferaseIBA 09/2013 - 03/2010
2	GD2 gangliosideIBA 09/2013 - 03/2010
2	Anti-Idiotypic AntibodiesIBA 01/2013 - 12/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2012 - 01/2012
2	Neoplasm Antigens (Tumor Antigens)IBA 07/2012 - 01/2012
2	CMPacetylneuraminate monooxygenase (CMP-N-acetylneuraminate monooxygenase)IBA 07/2012 - 12/2009
2	NucleophosminIBA 04/2012 - 10/2011
2	Aluminum Hydroxide (Algeldrate)FDA Link 01/2012 - 01/2012
2	GlycolipidsIBA 01/2012 - 03/2002
2	Cell-Penetrating PeptidesIBA 07/2011 - 01/2008
2	Formaldehyde (Formol)FDA Link 01/2011 - 01/2010
2	ParaffinIBA 01/2011 - 01/2010
2	N-glycolylneuraminyllactosylceramide (HD3)IBA 01/2011 - 01/2010
2	Tissue Inhibitor of Metalloproteinase-1IBA 11/2006 - 01/2003
2	Peptide Hydrolases (Proteases)FDA Link 10/2006 - 01/2002
2	Metalloproteases (Metalloproteinases)IBA 10/2006 - 01/2005
2	beta-chimaerinIBA 01/2005 - 05/2003
1	Fluorouracil (Carac)FDA LinkGeneric 12/2023
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 12/2023
1	deoxyuridine triphosphateIBA 12/2023
1	Cyclin-Dependent Kinase Inhibitor p21IBA 12/2023
1	Biosimilar PharmaceuticalsIBA 08/2023
1	Bevacizumab (Avastin)FDA Link 08/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2023
1	Small Interfering RNA (siRNA)IBA 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 01/2022
1	Interferon-gamma (Interferon, gamma)IBA 01/2022
1	Free RadicalsIBA 07/2020

Therapy/Procedure

18	Therapeutics 12/2023 - 03/2002
10	Drug Therapy (Chemotherapy) 12/2023 - 09/2008
9	Immunotherapy 01/2022 - 11/2004
4	Intravenous Administration 12/2023 - 09/2008
2	Radiotherapy 10/2020 - 01/2016
2	Blood Transfusion (Blood Transfusions) 09/2018 - 11/2017
2	Operative Surgical Procedures 01/2015 - 12/2010
1	Oral Administration 07/2020
1	Castration 01/2019